Dr. Mark Huffman and Dr. Yazan Daaboul Discuss: QUARTET USA – Efficacy and Safety of a Quadruple Ultra-Low-Dose Treatment for Hypertension (QUARTET USA): A Randomized Controlled Trial November 6, 2022 Disclosures: TBD
Dr. Paul Kalra and Dr. C. Michael Gibson Discuss: IRONMAN – Randomized Trial of Intravenous Ferric Derisomaltose in Heart Failure with Reduced Ejection Fraction November 6, 2022 Disclosures: TBD
Dr. Petr Ostadal and Dr. C. Michael Gibson Discuss: ECMO-CS – Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Primary Results from the Multicenter, Randomized ECMO-CS Trial November 6, 2022 Disclosures: TBD
Dr. David Hare and Dr. Yazan Daaboul Discuss: RAPCO – Radial Artery Patency and Clinical Outcomes (RAPCO) Randomized Trials – The 15-Year Clinical Outcomes Comparing Radial Artery with Right Internal Thoracic Artery or With Saphenous Vein Grafting November 6, 2022 Disclosures: TBD
Dr. Areef Ishani and Dr. Yazan Daaboul Discuss: DCP – Chlorthalidone Compared to Hydrochlorothiazide for the Prevention of Cardiovascular Events in Patients with Hypertension November 5, 2022 Disclosures: TBD
Dr. Julian Gillmore, Dr. David Lebwohl, and Dr. C. Michael Gibson Discuss: First-in-Human in vivo Crispr/Cas9 Editing of the Ttr Gene by Ntla-2001 in Patients with Transthyretin Amyloidosis With Cardiomyopathy November 5, 2022 Disclosures: TBA
Dr. Robert Mentz and Dr. C. Michael Gibson Discuss: TRANSFORM-HF – Comparative Effectiveness of Torsemide versus Forsumid in Heart Failure: Primary Results of the TRANSFORM-HF Trial November 5, 2022 Disclosures: TBD
Dr. Aruna Pradhan Presents: PROMINENT – A Randomized Trial of Pemafibrate for Triglyceride Reduction in the Prevention of Cardiovascular Disease November 5, 2022 Disclosures: TBD
Snackable Health® with Dr. Gibson and Dr. Kohli: What harm could we be exposing ourselves to when using various hair products? Dr. Payal Kohli and I talk about the new findings regarding the safety of hair products, specifically dry shampoo November 4, 2022 Disclosures: TBD
Snackable Health® with Dr. Gibson and Dr. Kohli: Paxlovid persistence is the new paxlovid rebound. Our CDC Director, Dr. Walensky, has had a paxlovid rebound this week. Dr. Payal Kohli and I dive deeper into what constitutes a paxlovid rebound. What does this mean for the effectiveness of paxlovid? November 4, 2022 Disclosures: TBD
